No retraction, correction or concern found when last checked on Oct 31, 2026.
Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2
Yufei Xiang, Sham Nambulli, Zhengyun Xiao and 6 more (opens in a new tab)
Science · 2020 · CC BY
doi:10.1101/2020.08.24.264333 (opens in a new tab)
Abstract
Nanobodies that neutralize Monoclonal antibodies that bind to the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) show therapeutic promise but must be produced in mammalian cells and need to be delivered intravenously. By contrast, single-domain antibodies called nanobodies can be produced in bacteria or yeast, and their stability may enable aerosol delivery. Two papers now report nanobodies that bind tightly to spike and efficiently neutralize SARS-CoV-2 in cells. Schoof et al. screened a yeast surface display of synthetic nanobodies and Xiang et al. screened anti-spike nanobodies produced by a llama. Both groups identified highly potent nanobodies that lock the spike protein in an inactive conformation. Multivalent constructs of selected nanobodies achieved even more potent neutralization. Science , this issue p. 1473 , p. 1479
Cited by papers we hold 9
- A highly photostable and bright green fluorescent protein · 2022Corrected
- Isolation of SARS-CoV-2-blocking recombinant antibody fragments and characterisation of their binding to variant spike proteins · 2022Not checked
- Broadly neutralizing and protective nanobodies against SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.4/5 and diverse sarbecoviruses · 2022Not checked
- A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations · 2022No notice
- Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy · 2021No notice
- A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19 · 2021No notice
- Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants · 2021No notice
- Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice · 2021No notice
- How can nanotechnology help to combat COVID-19? Opportunities and urgent need · 2020No notice
Questions about this paper
We email you if it is retracted, withdrawn, corrected or flagged.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.